Discover how cfDNA fragmentome tests could help detect liver disease early and track health. Learn more about this emerging ...
Leerink Global Healthcare Conference 2026 March 11, 2026 8:00 AM EDTCompany ParticipantsSam Samad - Executive VP ...
Built on groundbreaking research from Israel ’s Weizmann Institute of Science, Promise Bio developed the first cloud-based platform for broad epiproteomics, helping researchers uncover disease ...
Advancing the Discovery of Novel Therapies and Building an Integrated Drug Discovery Platform by Combining PPI Science with AI - ...
AI Nose deployment into front-end wafer fabrication facilities marks a critical validation step in semiconductor manufacturing environmentsRecurring revenue visibility strengthens as AI Nose deploymen ...
The AACE update to its 2026 algorithm for the management of type 2 diabetes includes a new section on diabetes classification ...
Chronic hepatitis D virus (HDV) coinfection in people with chronic hepatitis B is associated with rapid progression to liver cirrhosis and high mortality. In 2020, the estimated global HDV burden ...
In April 2025, the FDA announced plans to shift biomedical research for monoclonal antibodies and other medications away from ...
IgA nephropathy, an immune assault on the kidneys, is often missed. New treatments mean that spotting it sooner might save ...
Artificial intelligence is rapidly transforming health care. AI systems can now detect diabetic eye disease from retinal ...
An innovative platform developed by PKU researchers called "cf-EpiTracing" has proved capable of detecting and tracing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results